Home
>
National Drug Code (NDC)
>
Transderm Scop
Transderm Scop - 10019-553-02 - (Scopalamine)
Drug Information of Transderm Scop
| Product NDC: | 10019-553 |
| Proprietary Name: | Transderm Scop |
| Non Proprietary Name: | Scopalamine |
| Active Ingredient(s): | 1 mg/3d & nbsp; Scopalamine |
| Administration Route(s): | TRANSDERMAL |
| Dosage Form(s): | PATCH, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Transderm Scop
| Product NDC: | 10019-553 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017874 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030101 |
Package Information of Transderm Scop
| Package NDC: | 10019-553-02 |
| Package Description: | 24 POUCH in 1 BOX (10019-553-02) > 1 PATCH in 1 POUCH > 3 d in 1 PATCH |
NDC Information of Transderm Scop
| NDC Code | 10019-553-02 |
| Proprietary Name | Transderm Scop |
| Package Description | 24 POUCH in 1 BOX (10019-553-02) > 1 PATCH in 1 POUCH > 3 d in 1 PATCH |
| Product NDC | 10019-553 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Scopalamine |
| Dosage Form Name | PATCH, EXTENDED RELEASE |
| Route Name | TRANSDERMAL |
| Start Marketing Date | 20030101 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | SCOPOLAMINE |
| Strength Number | 1 |
| Strength Unit | mg/3d |
| Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
